Chaperon-Mediated single molecular approach toward modulating aβ peptide aggregation

Nano Letters

Volumn 9, Issue 12, 2009, Pages 4066-4072

  Liu, Lei ^a   Zhang, Lan ^a   Mao, Xiaobo ^a   Niu, Lin ^a   Yang, Yanlian ^a   Wang, Chen ^a  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGGREGATION BEHAVIOR; ALZHEIMER'S DISEASE; AMYLOID PEPTIDES; AQUEOUS SOLUTIONS; MOLECULAR APPROACH; MOLECULAR LEVELS; PEPTIDE AGGREGATION;

AMINES; MODULATION; PEPTIDES; SCANNING TUNNELING MICROSCOPY;

LIGHT MODULATORS;

AMYLOID BETA PROTEIN; CHAPERONE; MULTIPROTEIN COMPLEX; NANOMATERIAL;

ARTICLE; CHEMISTRY; CONFORMATION; CRYSTALLIZATION; MATERIALS TESTING; METHODOLOGY; NANOTECHNOLOGY; PARTICLE SIZE; SURFACE PROPERTY; ULTRASTRUCTURE;

AMYLOID BETA-PROTEIN; CRYSTALLIZATION; MATERIALS TESTING; MOLECULAR CHAPERONES; MOLECULAR CONFORMATION; MULTIPROTEIN COMPLEXES; NANOSTRUCTURES; NANOTECHNOLOGY; PARTICLE SIZE; SURFACE PROPERTIES;

EID: 71949110860     PISSN: 15306984     EISSN: None     Source Type: Journal    
DOI: 10.1021/nl902256b     Document Type: Article

References (48)

1. Shastry, B. S. Neurodegenerative disorders of protein aggregation. Neurochem. Int. 2003, 43, 1.
2. Roberson, E. D.; Mucke, L. 100 years and counting: prospects for defeating Alzheimer's disease. Science 2006, 314, 781. (Pubitemid 44706637)
3. Goedert, M.; Spillantini, M. G. A century of Alzheimer's disease. Science 2006, 314, 111.
4. Brody, D. L.; Magnoni, S. Amyloid-β dynamics correlate with neurological status in the injured human brain. Science 2008, 327, 1221.
5. Makin, O. S.; Serpell, L. C. Structures for amyloid fibrils. FEBS. J. 2005, 272, 5950.
6. Lambert, M. P.; Klein, W. L. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 6448.
7. Lashuel, H. A.; Hartley, D.; Petre, B. M.; Walz, T.; Lansbury, P. T. Amyloid pores from pathogenic mutations. Nature 2002, 418, 291.
8. Quist, A.; Doudevski, I.; Lal, R. Amyloid ion channels: A common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 10427.
9. Irie, K.; Murakami, K.; Masuda, Y. Structure of beta-amyloid fibrils and its relevance to their neurotoxicity: implications for pathogenesis of Alzheimer's disease. J. Biosci. Bioeng. 2005, 99, 437. (Pubitemid 40874521)
10. Kirschner, D. A.; Inouye, H.; Duffy, L. K.; Sinclair, A.; Lind, M.; Selkoe, D. J. Synthetic peptide homologous to beta-protein from Alzheimer-disease forms amyloid-like fibrils in vitro. Proc. Natl. Acad Sci. U.S.A. 1987, 84, 6953.
11. Mikros, E.; Benaki, D.; Humpfer, E.; Spraul, M.; Loukas, S.; Stassinopoulou, C. I.; Pelecanou, M. High-resolution NMR spectroscopy of the beta-amyloid(1-28) fibril typical for Alzheimer's disease. Angew. Chem., Int. Ed. 2001, 40, 3603. (Pubitemid 32953011)
12. Pike, C. J.; Burdick, D.; Walencewicz, A. J.; Glabe, C. G.; Cotman, C. W. Neurodegeneration induced by beta-amyloid peptides invitro - the role of peptide assembly state. J. Neurosci. 1993, 13, 1676.
13. Behl, C.; Davis, J. B.; Lesley, R.; Schubert, D. Hydrogen-peroxide mediates amyloid-beta protein toxicity. Cell 1994, 77, 817. (Pubitemid 24187680)
14. Shearman, M. S.; Ragan, C. I.; Iversen, L. L. Inhibition of Pc12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell-death. Proc. Natl. Acad. Sci. U.S.A. 1994, 97, 1470.
15. Lorenzo, A.; Yankner, B. A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 12243.
16. Kang, J.; Lemaire, H. G.; Unterbeck, A.; Salbaum, J. M.; Masters, C. L.; Grzeschik, K. H.; Multhaup, G.; Beyreuther, K.; Mullerhill, B. The precursor of Alzheimers-disease amyloid-A4 protein resembles a cell-surface receptor. Nature 1987, 325, 733.
17. Masters, C. L.; Simms, G.; Weinman, N. A.; Multhaup, G.; McDonald, B. L.; Beyreuther, K. Amyloid plaque core protein in Alzheimer-disease and down syndrome. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 4245.
18. Westlind-Danielsson, A.; Arnerup, G. Spontaneous in vitro formation of supramolecular beta-amyloid structures, "beta amy balls", by betaamyloid 1-40 peptide. Biochemistry 2001, 40, 14736.
19. (19) Selenica, M. L.; Wang, X.; Ostergaard-Pedersen, L.; Westlind-Danielsson, A.; Grubb, A. Cystatin C reduces the in vitro formation of soluble A beta 1-42 oligomers and protofibrils. Scand. J. Clin. Lab. Invest. 2007, 67, 179. (Pubitemid 46410600)
20. Lau, T. L.; Ambroggio, E. E.; Tew, D. J.; Cappai, R.; Masters, C. L.; Fidelio, G. D.; Barnham, K. J.; Separovic, F. Amyloid-beta peptide disruption of lipid membranes and the effect of metal ions. J. Mol. Biol. 2006, 356, 759. (Pubitemid 43139335)
21. Petkova, A. T.; Ishii, Y.; Balbach, J. J.; Antzutkin, O. N.; Leapman, R. D.; Delaglio, F.; Tycko, R. A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. USA. 2002, 99, 16742. (Pubitemid 36034043)
22. Tycko, R. Molecular structure of amyloid fibrils: insights from solid-state NMR. Q. Rev. Biophys. 2006, 39, 1.
23. Malinchik, S. B.; Inouye, H.; Szumowski, K. E.; Kirschner, D. A. Structural analysis of Alzheimer's beta(1-40) amyloid: protofilament assembly of tubular fibrils. Biophys. J. 1998, 74, 537.
24. Serpell, L. C.; Blake, C. C. F.; Fraser, P. E. Molecular structure of a fibrillar Alzheimer's A beta fragment. Biochemistry. 2000, 39, 13269.
25. Lansbury, P. T.; Costa, P. R.; Griffiths, J. M.; Simon, E. J.; Auger, M.; Halverson, K. J.; Kocisko, D. A.; Hendsch, Z. S.; Ashburn, T. T.; Spencer, R. G. S.; Tidor, B.; Griffin, R. G. Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallelsheet comprising a C-terminal peptide. Nat. Struct. Biol. 1995, 2, 990.
26. Nelson, R.; Sawaya, M. R.; Balbirnie, M.; Eisenberg, D. Structure of the cross-β spine of amyloid-like fibrils. Nature 2005, 435, 113.
27. Sawaya, M. R.; Sambashivan, S.; Nelson, R.; Eisenberg, D. Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature 2007, 447, 453.
28. Hilbich, C.; Kisters-Woike, B.; Reed, J.; Masters, C. L.; Beyreuther, K. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. J. Mol. Biol. 1991, 278, 149.
29. Matsuzaki,K.;Horikiri,C.Interactionsofamyloidβ-peptide(1-40) withganglioside-containingmembranes.Biochemistry1999,38,4137. (Pubitemid129514677)
30. Kudernac, T.; Lei, S. B.; Elemans, J. A. A. W.; De Feyter, S. Two-dimensional supramolecular self-assembly: nanoporous networks on surface. Chem. Soc. Rev. 2009, 38, 402.
31. Barth, J. V.; Costantini, G.; Kern, K. Engineering atomic and molecular nanostructures at surfaces. Nature 2005, 437, 671. (Pubitemid 41486530)
32. Lingenfelder, M.; Tomba, G.; Costantini, G.; Ciacchi, L. C.; De Vita, A.; Kern, K. Tracking the chiral recognition of adsorbed dipeptides at the single-molecule level. Angew. Chem., Int. Ed. 2007, 46, 4492. (Pubitemid 46954602)
33. Ma, X. J.; Liu, L.; Mao, X. B.; Niu, L.; Deng, K.; Wu, W. H.; Li, Y. M.; Yang, Y. L.; Wang, C. Amyloid-β (1-42) folding multiplicity and single molecule binding behavior studied by STM. J. Mol. Biol. 2009, 388, 894.
34. Soto, C.; Sigurdsson, E. M.; Morelli, L.; Kumar, R. A.; Castano, E. M.; Frangione, B. Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat. Med. 1998, 4, 822. (Pubitemid 28331024)
35. Mingeot-Leclercq, M. P.; Lins, L.; Bensliman, M.; Van Bambeke, F.; van der Smissen, P.; Peuvot, J.; Schanck, A.; Brasseur, R. Membrane destabilization induced by beta-amyloid peptide 29-42: importance of the amino-terminus. Chem. Phys. Lipids. 2002, 120, 57.
36. Itoh, S. G.; Okamoto, Y. Amyloid-β (29-42) dimer formations studied by a multicanonical-multioverlap molecular dynamics simulation. J. Phys. Chem. B 2008, 112, 2767.
37. Demeester, N.; Baier, G.; Enzinger, C.; Goethals, M.; Vandekerckhove, J.; Rosseneu, M.; Labeur, C. Apoptosis induced in neuronal cells by C-terminal amyloid beta-fragments is correlated with their aggregation properties in phospholipid membranes. Mol. Membr. Biol. 2000, 17, 219.
38. Arimon, M.; Diez-Perez, I.; Kogan, M. J.; Durany, N.; Giralt, E.; Sanz, F.; Fernandez-Busquets, X. Fine structure study of A beta(1-42) fibrillogenesis with atomic force microscopy. FASEB J. 2005, 19, 1344.
39. Kowalewski, T.; Holtzman, D. M. In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 3688.
40. Miyazawa, T.; Blout, E. R. Infrared spectra of polypeptides in various conformations - amide I and II bands. J. Am. Chem. Soc. 1961, 83, 712.
41. Gestwicki, J. E.; Crabtree, G. R.; Graef, I. A. Harnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation. Science. 2004, 306, 865.
42. Ono, K.; Naiki, H.; Yamada, M. The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fA beta), as well as destabilize preformed fA beta. Curr. Pharm. Design. 2006, 12, 4357. (Pubitemid 44718294)
43. Xu, B.; Yin, S. X.; Wang, C.; Zeng, Q. D.; Qiu, X. H.; Bai, C. L. Identification of hydrogen bond characterizations of isomeric 4Bpy and 2Bpy by STM. Surf. Interface Anal. 2001, 32, 245.
44. Pauling, L.; Corey, R. B. Two rippled-sheet configurations of polypeptide chains, and a note about the pleated sheets. Proc. Natl. Acad. Sci. U.S.A. 1953, 39, 253.
45. Lei, S. B.; Wang, C.; Wan, L. J.; Bai, C. L. Site selective adsorption and templated assembling: effect of organic-organic heterogeneous interface studied by scanning tunneling microscopy. J. Phys. Chem. B 2004, 108, 1173.
46. Lei, S. B.; Deng, K.; Yang, Y. L.; Zeng, Q. D.; Wang, C.; Jiang, J. Z. Electic driven molecular switching of asymmetric tris(phthalocyaninato) lutetium tirple-decker complex at the liquid/solid interface. Nano Lett. 2008, 8, 1836.
47. Klein, W. L. Aβ toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem. Int. 2002, 42, 345.
48. De Felice, F. G.; Velasco, P. T.; Lambert, M. P.; Viola, K.; Fernandez, S. J.; Ferreira, S. T.; Klein, W. L. Aβ oligomers induce neuronal oxidative stress through an N-Methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J. Bio. Chem. 2007, 282, 11590.